'Novel PET radiochemistries' webinar
Once considered a specialized imaging modality, PET is transitioning to the mainstream of the preclinical molecular imaging field and is considered to be the molecular imaging modality of choice for a variety of emerging applications in drug discovery and basic science research.
In this webinar the presenters will discuss novel radiochemistry approaches their groups are employing to gain further understanding of disease development and progression. Dr. Timothy DeGrado from the Mayo Clinic will highlight a new cell labeling technique that allows longitudinal imaging of cell trafficking over the course of weeks in a quantitative, non-invasive manner. Dr. Roger Schibli from ETH Zurich will discuss how his radiochemistry efforts have led to the development of several new radioisotopes for in vivo imaging applications and therapeutic intervention.
Join us for this thought provoking discussion of the current and future states of preclinical PET imaging.
Click the link below to register to watch the event online.
